Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 292 entries
Sorted by: Best Match Show Resources per page
A rare pleural mucinous cystadenocarcinoma mimicking loculated empyema initially: A case report.

The Indian journal of radiology & imaging

Moon SM, Seon HJ, Choi YD, Song SY.
PMID: 24604931
Indian J Radiol Imaging. 2013 Oct;23(4):301-3. doi: 10.4103/0971-3026.125568.

We report a case of pleural mucinous cystadenocarcinoma which was mistaken to be a loculated empyema on chest CT. To the best of our knowledge, this entity has never been previously reported in literature.

Cite
Moon SM, Seon HJ, Choi YD, et al. A rare pleural mucinous cystadenocarcinoma mimicking loculated empyema initially: A case report. Indian J Radiol Imaging. 2013;23(4):301-3doi: 10.4103/0971-3026.125568.
Moon, S. M., Seon, H. J., Choi, Y. D., & Song, S. Y. (2013). A rare pleural mucinous cystadenocarcinoma mimicking loculated empyema initially: A case report. The Indian journal of radiology & imaging, 23(4), 301-3. https://doi.org/10.4103/0971-3026.125568
Moon, Sung Min, et al. "A rare pleural mucinous cystadenocarcinoma mimicking loculated empyema initially: A case report." The Indian journal of radiology & imaging vol. 23,4 (2013): 301-3. doi: https://doi.org/10.4103/0971-3026.125568
Moon SM, Seon HJ, Choi YD, Song SY. A rare pleural mucinous cystadenocarcinoma mimicking loculated empyema initially: A case report. Indian J Radiol Imaging. 2013 Oct;23(4):301-3. doi: 10.4103/0971-3026.125568. PMID: 24604931; PMCID: PMC3932569.
Copy Download .nbib Format: NLM
Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis.

Experimental hematology & oncology

Smith BD, Beach CL, Mahmoud D, Weber L, Henk HJ.
PMID: 24666795
Exp Hematol Oncol. 2014 Mar 25;3(1):10. doi: 10.1186/2162-3619-3-10.

BACKGROUND: This study examined patient outcomes using real world data for acute myeloid leukemia (AML) patients initiating treatment.METHODS: A retrospective, administrative claims-based, comparative analysis was developed to study outcomes for AML patients initiating treatment with decitabine or azacitidine between...

Cite
Smith BD, Beach CL, Mahmoud D, et al. Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Exp Hematol Oncol. 2014;3(1):10doi: 10.1186/2162-3619-3-10.
Smith, B. D., Beach, C. L., Mahmoud, D., Weber, L., & Henk, H. J. (2014). Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Experimental hematology & oncology, 3(1), 10. https://doi.org/10.1186/2162-3619-3-10
Smith, B Douglas, et al. "Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis." Experimental hematology & oncology vol. 3,1 (2014): 10. doi: https://doi.org/10.1186/2162-3619-3-10
Smith BD, Beach CL, Mahmoud D, Weber L, Henk HJ. Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Exp Hematol Oncol. 2014 Mar 25;3(1):10. doi: 10.1186/2162-3619-3-10. PMID: 24666795; PMCID: PMC3994315.
Copy Download .nbib Format: NLM
Application of Chemical Shift Imaging for Simultaneous and Fast Acquisition of NMR Spectra on Multiple Samples.

Angewandte Chemie (International ed. in English)

Ross A, Schlotterbeck G, Senn H, von Kienlin M.
PMID: 29712067
Angew Chem Int Ed Engl. 2001 Sep 03;40(17):3243-3245. doi: 10.1002/1521-3773(20010903)40:17<3243::AID-ANIE3243>3.0.CO;2-F.

A reduction of a factor of 10 in the time needed to measure highly resolved NMR spectra of multiple samples can be achieved with any NMR spectrometer by using a combination of chemical shift imaging and a compartmented detection...

Cite
Ross A, Schlotterbeck G, Senn H, et al. Application of Chemical Shift Imaging for Simultaneous and Fast Acquisition of NMR Spectra on Multiple Samples. Angew Chem Int Ed Engl. 2001;40(17):3243-3245doi: 10.1002/1521-3773(20010903)40:17<3243::AID-ANIE3243>3.0.CO;2-F.
Ross, A., Schlotterbeck, G., Senn, H., & von Kienlin, M. (2001). Application of Chemical Shift Imaging for Simultaneous and Fast Acquisition of NMR Spectra on Multiple Samples. Angewandte Chemie (International ed. in English), 40(17), 3243-3245. https://doi.org/10.1002/1521-3773(20010903)40:17<3243::AID-ANIE3243>3.0.CO;2-F
Ross, Alfred, et al. "Application of Chemical Shift Imaging for Simultaneous and Fast Acquisition of NMR Spectra on Multiple Samples." Angewandte Chemie (International ed. in English) vol. 40,17 (2001): 3243-3245. doi: https://doi.org/10.1002/1521-3773(20010903)40:17<3243::AID-ANIE3243>3.0.CO;2-F
Ross A, Schlotterbeck G, Senn H, von Kienlin M. Application of Chemical Shift Imaging for Simultaneous and Fast Acquisition of NMR Spectra on Multiple Samples. Angew Chem Int Ed Engl. 2001 Sep 03;40(17):3243-3245. doi: 10.1002/1521-3773(20010903)40:17<3243::AID-ANIE3243>3.0.CO;2-F. PMID: 29712067.
Copy Download .nbib Format: NLM
NMR and MS Methods for Metabolomics.

Methods in molecular biology (Clifton, N.J.)

Amberg A, Riefke B, Schlotterbeck G, Ross A, Senn H, Dieterle F, Keck M.
PMID: 28748468
Methods Mol Biol. 2017;1641:229-258. doi: 10.1007/978-1-4939-7172-5_13.

Metabolomics, also often referred as "metabolic profiling," is the systematic profiling of metabolites in biofluids or tissues of organisms and their temporal changes. In the last decade, metabolomics has become more and more popular in drug development, molecular medicine,...

Cite
Amberg A, Riefke B, Schlotterbeck G, et al. NMR and MS Methods for Metabolomics. Methods Mol Biol. 2017;1641:229-258doi: 10.1007/978-1-4939-7172-5_13.
Amberg, A., Riefke, B., Schlotterbeck, G., Ross, A., Senn, H., Dieterle, F., & Keck, M. (2017). NMR and MS Methods for Metabolomics. Methods in molecular biology (Clifton, N.J.), 1641229-258. https://doi.org/10.1007/978-1-4939-7172-5_13
Amberg, Alexander, et al. "NMR and MS Methods for Metabolomics." Methods in molecular biology (Clifton, N.J.) vol. 1641 (2017): 229-258. doi: https://doi.org/10.1007/978-1-4939-7172-5_13
Amberg A, Riefke B, Schlotterbeck G, Ross A, Senn H, Dieterle F, Keck M. NMR and MS Methods for Metabolomics. Methods Mol Biol. 2017;1641:229-258. doi: 10.1007/978-1-4939-7172-5_13. PMID: 28748468.
Copy Download .nbib Format: NLM
Synthesis of Functionalized Indolines and Dihydrobenzofurans by Iron and Copper Catalyzed Aryl C-N and C-O Bond Formation.

The Journal of organic chemistry

Henry MC, Senn HM, Sutherland A.
PMID: 30520304
J Org Chem. 2019 Jan 04;84(1):346-364. doi: 10.1021/acs.joc.8b02888. Epub 2018 Dec 19.

A simple and effective one-pot, two-step intramolecular aryl C-N and C-O bond forming process for the preparation of a wide range of benzo-fused heterocyclic scaffolds using iron and copper catalysis is described. Activated aryl rings were subjected to a...

Cite
Henry MC, Senn HM, Sutherland A. Synthesis of Functionalized Indolines and Dihydrobenzofurans by Iron and Copper Catalyzed Aryl C-N and C-O Bond Formation. J Org Chem. 2018;84(1):346-364doi: 10.1021/acs.joc.8b02888.
Henry, M. C., Senn, H. M., & Sutherland, A. (2019). Synthesis of Functionalized Indolines and Dihydrobenzofurans by Iron and Copper Catalyzed Aryl C-N and C-O Bond Formation. The Journal of organic chemistry, 84(1), 346-364. https://doi.org/10.1021/acs.joc.8b02888
Henry, Martyn C, et al. "Synthesis of Functionalized Indolines and Dihydrobenzofurans by Iron and Copper Catalyzed Aryl C-N and C-O Bond Formation." The Journal of organic chemistry vol. 84,1 (2019): 346-364. doi: https://doi.org/10.1021/acs.joc.8b02888
Henry MC, Senn HM, Sutherland A. Synthesis of Functionalized Indolines and Dihydrobenzofurans by Iron and Copper Catalyzed Aryl C-N and C-O Bond Formation. J Org Chem. 2019 Jan 04;84(1):346-364. doi: 10.1021/acs.joc.8b02888. Epub 2018 Dec 19. PMID: 30520304.
Copy Download .nbib Format: NLM
Survival outcomes following laparoscopic vs open surgery for non-metastatic rectal cancer: a two-center cohort study with propensity score matching.

Gastroenterology report

Tan KL, Deng HJ, Chen ZQ, Mou TY, Liu H, Xie RS, Liang XM, Fan XH, Li GX.
PMID: 32843980
Gastroenterol Rep (Oxf). 2020 Aug 19;8(4):319-325. doi: 10.1093/gastro/goaa046. eCollection 2020 Aug.

BACKGROUND?>: Laparoscopic surgery for rectal cancer is commonly performed in China. However, compared with open surgery, the effectiveness of laparoscopic surgery, especially the long-term survival, has not been sufficiently proved.METHODS?>: Data of eligible patients with non-metastatic rectal cancer at...

Cite
Tan KL, Deng HJ, Chen ZQ, et al. Survival outcomes following laparoscopic vs open surgery for non-metastatic rectal cancer: a two-center cohort study with propensity score matching. Gastroenterol Rep (Oxf). 2020;8(4):319-325doi: 10.1093/gastro/goaa046.
Tan, K. L., Deng, H. J., Chen, Z. Q., Mou, T. Y., Liu, H., Xie, R. S., Liang, X. M., Fan, X. H., & Li, G. X. (2020). Survival outcomes following laparoscopic vs open surgery for non-metastatic rectal cancer: a two-center cohort study with propensity score matching. Gastroenterology report, 8(4), 319-325. https://doi.org/10.1093/gastro/goaa046
Tan, Kang-Lian, et al. "Survival outcomes following laparoscopic vs open surgery for non-metastatic rectal cancer: a two-center cohort study with propensity score matching." Gastroenterology report vol. 8,4 (2020): 319-325. doi: https://doi.org/10.1093/gastro/goaa046
Tan KL, Deng HJ, Chen ZQ, Mou TY, Liu H, Xie RS, Liang XM, Fan XH, Li GX. Survival outcomes following laparoscopic vs open surgery for non-metastatic rectal cancer: a two-center cohort study with propensity score matching. Gastroenterol Rep (Oxf). 2020 Aug 19;8(4):319-325. doi: 10.1093/gastro/goaa046. eCollection 2020 Aug. PMID: 32843980; PMCID: PMC7434561.
Copy Download .nbib Format: NLM
Does evidence support the high expectations placed in precision medicine? A bibliographic review.

F1000Research

Cortés J, González JA, Medina MN, Vogler M, Vilaró M, Elmore M, Senn SJ, Campbell M, Cobo E.
PMID: 31143439
F1000Res. 2018 Jan 09;7:30. doi: 10.12688/f1000research.13490.2. eCollection 2018.

No abstract available.

Cite
Cortés J, González JA, Medina MN, et al. Does evidence support the high expectations placed in precision medicine? A bibliographic review. F1000Res. 2018;7:30doi: 10.12688/f1000research.13490.2.
Cortés, J., González, J. A., Medina, M. N., Vogler, M., Vilaró, M., Elmore, M., Senn, S. J., Campbell, M., & Cobo, E. (2018). Does evidence support the high expectations placed in precision medicine? A bibliographic review. F1000Research, 730. https://doi.org/10.12688/f1000research.13490.2
Cortés, Jordi, et al. "Does evidence support the high expectations placed in precision medicine? A bibliographic review." F1000Research vol. 7 (2018): 30. doi: https://doi.org/10.12688/f1000research.13490.2
Cortés J, González JA, Medina MN, Vogler M, Vilaró M, Elmore M, Senn SJ, Campbell M, Cobo E. Does evidence support the high expectations placed in precision medicine? A bibliographic review. F1000Res. 2018 Jan 09;7:30. doi: 10.12688/f1000research.13490.2. eCollection 2018. PMID: 31143439; PMCID: PMC6524747.2.
Copy Download .nbib Format: NLM
Does evidence support the high expectations placed in precision medicine? A bibliographic review.

F1000Research

Cortés J, González JA, Medina MN, Vogler M, Vilaró M, Elmore M, Senn SJ, Campbell M, Cobo E.
PMID: 31143439
F1000Res. 2018 Jan 09;7:30. doi: 10.12688/f1000research.13490.4. eCollection 2018.

No abstract available.

Cite
Cortés J, González JA, Medina MN, et al. Does evidence support the high expectations placed in precision medicine? A bibliographic review. F1000Res. 2018;7:30doi: 10.12688/f1000research.13490.4.
Cortés, J., González, J. A., Medina, M. N., Vogler, M., Vilaró, M., Elmore, M., Senn, S. J., Campbell, M., & Cobo, E. (2018). Does evidence support the high expectations placed in precision medicine? A bibliographic review. F1000Research, 730. https://doi.org/10.12688/f1000research.13490.4
Cortés, Jordi, et al. "Does evidence support the high expectations placed in precision medicine? A bibliographic review." F1000Research vol. 7 (2018): 30. doi: https://doi.org/10.12688/f1000research.13490.4
Cortés J, González JA, Medina MN, Vogler M, Vilaró M, Elmore M, Senn SJ, Campbell M, Cobo E. Does evidence support the high expectations placed in precision medicine? A bibliographic review. F1000Res. 2018 Jan 09;7:30. doi: 10.12688/f1000research.13490.4. eCollection 2018. PMID: 31143439; PMCID: PMC6524747.
Copy Download .nbib Format: NLM
Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine.

Cell discovery

Peng P, Deng HJ, Hu J, Wei XY, Xue JJ, Li TT, Fang L, Liu BZ, Jin AS, Xu FL, Wu K, Long QX, Chen J, Wang K, Tang N, Huang AL.
PMID: 34400614
Cell Discov. 2021 Aug 17;7(1):68. doi: 10.1038/s41421-021-00311-z.

No abstract available.

Cite
Peng P, Deng HJ, Hu J, et al. Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine. Cell Discov. 2021;7(1):68doi: 10.1038/s41421-021-00311-z.
Peng, P., Deng, H. J., Hu, J., Wei, X. Y., Xue, J. J., Li, T. T., Fang, L., Liu, B. Z., Jin, A. S., Xu, F. L., Wu, K., Long, Q. X., Chen, J., Wang, K., Tang, N., & Huang, A. L. (2021). Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine. Cell discovery, 7(1), 68. https://doi.org/10.1038/s41421-021-00311-z
Peng, Pai, et al. "Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine." Cell discovery vol. 7,1 (2021): 68. doi: https://doi.org/10.1038/s41421-021-00311-z
Peng P, Deng HJ, Hu J, Wei XY, Xue JJ, Li TT, Fang L, Liu BZ, Jin AS, Xu FL, Wu K, Long QX, Chen J, Wang K, Tang N, Huang AL. Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine. Cell Discov. 2021 Aug 17;7(1):68. doi: 10.1038/s41421-021-00311-z. PMID: 34400614; PMCID: PMC8368000.
Copy Download .nbib Format: NLM
Immune memory in convalescent patients with asymptomatic or mild COVID-19.

Cell discovery

Long QX, Jia YJ, Wang X, Deng HJ, Cao XX, Yuan J, Fang L, Cheng XR, Luo C, He AR, Tang XJ, Hu JL, Hu Y, Tang N, Cai XF, Wang DQ, Hu J, Qiu JF, Liu BZ, Chen J, Huang AL.
PMID: 33767156
Cell Discov. 2021 Mar 25;7(1):18. doi: 10.1038/s41421-021-00250-9.

It is important to evaluate the durability of the protective immune response elicited by primary infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we systematically evaluated the SARS-CoV-2-specific memory B cell and T cell responses in healthy...

Cite
Long QX, Jia YJ, Wang X, et al. Immune memory in convalescent patients with asymptomatic or mild COVID-19. Cell Discov. 2021;7(1):18doi: 10.1038/s41421-021-00250-9.
Long, Q. X., Jia, Y. J., Wang, X., Deng, H. J., Cao, X. X., Yuan, J., Fang, L., Cheng, X. R., Luo, C., He, A. R., Tang, X. J., Hu, J. L., Hu, Y., Tang, N., Cai, X. F., Wang, D. Q., Hu, J., Qiu, J. F., Liu, B. Z., Chen, J., & Huang, A. L. (2021). Immune memory in convalescent patients with asymptomatic or mild COVID-19. Cell discovery, 7(1), 18. https://doi.org/10.1038/s41421-021-00250-9
Long, Quan-Xin, et al. "Immune memory in convalescent patients with asymptomatic or mild COVID-19." Cell discovery vol. 7,1 (2021): 18. doi: https://doi.org/10.1038/s41421-021-00250-9
Long QX, Jia YJ, Wang X, Deng HJ, Cao XX, Yuan J, Fang L, Cheng XR, Luo C, He AR, Tang XJ, Hu JL, Hu Y, Tang N, Cai XF, Wang DQ, Hu J, Qiu JF, Liu BZ, Chen J, Huang AL. Immune memory in convalescent patients with asymptomatic or mild COVID-19. Cell Discov. 2021 Mar 25;7(1):18. doi: 10.1038/s41421-021-00250-9. PMID: 33767156; PMCID: PMC7993859.
Copy Download .nbib Format: NLM
The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies.

Clinical pharmacology and therapeutics

Rivera DR, Henk HJ, Garrett-Mayer E, Christian JB, Belli AJ, Bruinooge SS, Espirito JL, Sweetnam C, Izano MA, Natanzon Y, Robert NJ, Walker MS, Cohen AB, Boyd M, Enewold L, Hansen E, Honnold R, Kushi L, Mishra Kalyani PS, Pe Benito R, Sakoda LC, Sharon E, Tymejczyk O, Valice E, Wagner J, Lasiter L, Allen JD.
PMID: 34664259
Clin Pharmacol Ther. 2022 Jan;111(1):283-292. doi: 10.1002/cpt.2453. Epub 2021 Nov 11.

The purpose of this study was to evaluate the potential collective opportunities and challenges of transforming real-world data (RWD) to real-world evidence for clinical effectiveness by focusing on aligning analytic definitions of oncology end points. Patients treated with a...

Cite
Rivera DR, Henk HJ, Garrett-Mayer E, et al. The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies. Clin Pharmacol Ther. 2021;111(1):283-292doi: 10.1002/cpt.2453.
Rivera, D. R., Henk, H. J., Garrett-Mayer, E., Christian, J. B., Belli, A. J., Bruinooge, S. S., Espirito, J. L., Sweetnam, C., Izano, M. A., Natanzon, Y., Robert, N. J., Walker, M. S., Cohen, A. B., Boyd, M., Enewold, L., Hansen, E., Honnold, R., Kushi, L., Mishra Kalyani, P. S., Pe Benito, R., Sakoda, L. C., Sharon, E., Tymejczyk, O., Valice, E., Wagner, J., Lasiter, L., & Allen, J. D. (2022). The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies. Clinical pharmacology and therapeutics, 111(1), 283-292. https://doi.org/10.1002/cpt.2453
Rivera, Donna R, et al. "The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies." Clinical pharmacology and therapeutics vol. 111,1 (2022): 283-292. doi: https://doi.org/10.1002/cpt.2453
Rivera DR, Henk HJ, Garrett-Mayer E, Christian JB, Belli AJ, Bruinooge SS, Espirito JL, Sweetnam C, Izano MA, Natanzon Y, Robert NJ, Walker MS, Cohen AB, Boyd M, Enewold L, Hansen E, Honnold R, Kushi L, Mishra Kalyani PS, Pe Benito R, Sakoda LC, Sharon E, Tymejczyk O, Valice E, Wagner J, Lasiter L, Allen JD. The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies. Clin Pharmacol Ther. 2022 Jan;111(1):283-292. doi: 10.1002/cpt.2453. Epub 2021 Nov 11. PMID: 34664259.
Copy Download .nbib Format: NLM
Expenditures among young adults with acute lymphoblastic leukemia by site of care.

Cancer

Wolfson JA, Bhatia S, Ginsberg J, Becker LK, Bernstein D, Henk HJ, Lyman GH, Nathan PC, Puccetti D, Wilkes JJ, Winestone LE, Kenzik KM.
PMID: 33465248
Cancer. 2021 Jun 01;127(11):1901-1911. doi: 10.1002/cncr.33413. Epub 2021 Jan 19.

BACKGROUND: Individuals diagnosed with acute lymphoblastic leukemia (ALL) between the ages of 22 and 39 years experience worse outcomes than those diagnosed when they are 21 years old or younger. Treatment at National Cancer Institute-designated Comprehensive Cancer Centers (CCC)...

Cite
Wolfson JA, Bhatia S, Ginsberg J, et al. Expenditures among young adults with acute lymphoblastic leukemia by site of care. Cancer. 2021;127(11):1901-1911doi: 10.1002/cncr.33413.
Wolfson, J. A., Bhatia, S., Ginsberg, J., Becker, L. K., Bernstein, D., Henk, H. J., Lyman, G. H., Nathan, P. C., Puccetti, D., Wilkes, J. J., Winestone, L. E., & Kenzik, K. M. (2021). Expenditures among young adults with acute lymphoblastic leukemia by site of care. Cancer, 127(11), 1901-1911. https://doi.org/10.1002/cncr.33413
Wolfson, Julie A, et al. "Expenditures among young adults with acute lymphoblastic leukemia by site of care." Cancer vol. 127,11 (2021): 1901-1911. doi: https://doi.org/10.1002/cncr.33413
Wolfson JA, Bhatia S, Ginsberg J, Becker LK, Bernstein D, Henk HJ, Lyman GH, Nathan PC, Puccetti D, Wilkes JJ, Winestone LE, Kenzik KM. Expenditures among young adults with acute lymphoblastic leukemia by site of care. Cancer. 2021 Jun 01;127(11):1901-1911. doi: 10.1002/cncr.33413. Epub 2021 Jan 19. PMID: 33465248.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 292 entries